Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
A new survey sponsored by Bayer revealed that many physicians report a lack of familiarity with chronic thromboembolic pulmonary hypertension (CTEPH)....
Bayer Animal Health, in coordination with Adopt-a-Pet.com, today launched Share For Shelters, a campaign designed to emphasize the love and...
In honor of national Prostate Cancer Awareness Month this September – a time when the community raises awareness for education, early detection and...
Bayer HealthCare announced today the expansion of the clinical development program for its oral non-steroidal mineralocorticoid receptor antagonist...
Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has approved Finacea® (azelaic acid) Foam, 15% for the topical...
In an effort to help many of the 1.2 million Americans who receive a cancer diagnosis each year1 deal with the significant emotional challenges of...
Bayer HealthCare and The Johns Hopkins University in Baltimore have entered into a five-year collaboration agreement to jointly develop new...
Bayer Healthcare, the makers of Coppertone®, kicked off an exciting multi-year deal with U.S. Soccer and the National Women's Soccer League to...
Bayer HealthCare LLC Animal Health today announced that Chad Malpass, DVM, a 2015 graduate of Tuskegee University School of Veterinary Medicine, is...
Results from a retrospective cohort study presented today at the American Thoracic Society (ATS) 2015 International Conference in Denver found that...
Bayer HealthCare will present data investigating pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in...
Bayer HealthCare Pharmaceuticals Inc. announced today the Company's line-up of oncology research to be presented in a scientific forum at the 51st...
Bayer HealthCare (Bayer) has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) on ISIS-FXIRx, an antisense...
Bayer HealthCare announced today that a study published online this week in The Journal of Minimally Invasive Gynecology reinforces findings from...
Bayer is pleased to announce today that the U.S. Food and Drug Administration (FDA) has accepted the filing for Bayer's supplemental Biologics...
In recognition of World Hemophilia Day and the global need for education about hemophilia, Bayer HealthCare will host an inaugural joint fellowship...
Bayer HealthCare today announced a $100 million investment in its Berkeley, Calif. manufacturing site to build a product testing facility that will...
Bayer HealthCare today announced the expansion of its global clinical development program for the investigational oncology compound copanlisib (BAY...
Bayer HealthCare (Bayer) has expanded its collaboration with the Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard...
Bayer HealthCare, the makers of Claritin®, the #1 selling non-drowsy allergy brand and Proud Sponsor of Spring, has teamed up with Grammy...
K9 Advantix® II from Bayer and K9s For Warriors today launched a three-month campaign that will enable dog owners to support Iraq and Afghanistan War ...
Bayer HealthCare announced today that it has contributed one million dollars to the Conquer Cancer Foundation of the American Society of Clinical...
Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for...
Leading patient advocacy organization Fight Colorectal Cancer and Bayer HealthCare are kicking off the 2015 One Million Strong campaign to spotlight...
Bayer HealthCare is joining the National Organization for Rare Disorders (NORD) and other patient groups in support of Rare Disease Day, February 28, ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.